Correlation Between Four Leaf and Esperion Therapeutics

Can any of the company-specific risk be diversified away by investing in both Four Leaf and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Four Leaf and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Four Leaf Acquisition and Esperion Therapeutics, you can compare the effects of market volatilities on Four Leaf and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Four Leaf with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Four Leaf and Esperion Therapeutics.

Diversification Opportunities for Four Leaf and Esperion Therapeutics

0.59

Correlation Coefficient

Four Leaf  Esperion Therapeutics

Very weak diversification

The 3 months correlation between Four and Esperion is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Four Leaf Acquisition and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Four Leaf is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Four Leaf Acquisition are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Four Leaf i.e., Four Leaf and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Four Leaf and Esperion Therapeutics

Given the investment horizon of 90 days Four Leaf is expected to generate 100.25 times less return on investment than Esperion Therapeutics. But when comparing it to its historical volatility, Four Leaf Acquisition is 58.61 times less risky than Esperion Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  191.00  in Esperion Therapeutics on September 13, 2024 and sell it today you would earn a total of  78.00  from holding Esperion Therapeutics or generate 40.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Four Leaf Acquisition  vs.  Esperion Therapeutics

Four Leaf Acquisition

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Four Leaf Acquisition are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Four Leaf is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Esperion Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Four Leaf and Esperion Therapeutics

The main advantage of trading using opposite Four Leaf and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Four Leaf position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.

The idea behind Four Leaf Acquisition and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.